Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|October 4, 2024
Association between radius axial low-frequency ultrasound velocity and bone fragility in primary hyperparathyroidismJessica Pepe, Luciano Colangelo, Daniele Diacinti, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2021
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTSAthanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, et al.
Bone|November 8, 2022
Impairment in muscle strength and its determinants in primary hyperparathyroidism: A study in postmenopausal womenViviana De Martino, Jessica Pepe, Federica Biamonte, et al.
Bone|November 1, 2024
Assessment of trabecular bone score (TBS) in the prediction of vertebral fracture in postmenopausal osteoporosisFederica Biamonte, Jessica Pepe, Luciano Colangelo, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 1, 2004
Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fracturesElisabetta Romagnoli, Vincenzo Carnevale, Italo Nofroni, et al.
Therapeutic Advances in Musculoskeletal Disease|October 22, 2019
Update on the safety and efficacy of teriparatide in the treatment of osteoporosisSalvatore Minisola, Cristiana Cipriani, Giada Della Grotta, et al.
Aging Clinical and Experimental Research|February 13, 2004
Impact of fractures on health care in a major university hospital in RomeElisabetta Romagnoli, Vincenzo Carnevale, Pierluigi Calandra, et al.
Journal of Bone Oncology|January 14, 2025
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMSFrancesco Bertoldo, Cristina Eller-Vainicher, Vittorio Fusco, et al.
Nutrients|November 9, 2024
Short-Term Effects of Escalating Doses of Cholecalciferol on FGF23 and 24,25(OH)2 Vitamin D Levels: A Preliminary InvestigationJessica Pepe, Luciano Colangelo, Roberta Pilotto, et al.
The Journal of Clinical Endocrinology and Metabolism|June 15, 2013
Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxisCristiana Cipriani, Elisabetta Romagnoli, Jessica Pepe, et al.
Pageof 11